Abstract
Although different types of drug-eluting stents (DES) are currently being used in percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease, limited data are available on the relative efficacy and safety profiles of different types of contemporary DES. To investigate the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
